EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ceramides as Biomarkers and Pharmacological Targets in Heart Failure Pathophysiology

Melania Gaggini iD, Cristina Vassalle iD

Biomolecules · 01.04.2026 · 16 (4) · 521

DOI: 10.3390/biom16040521 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 01.04.2026. Verfasst von Melania Gaggini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Physiology, National Research Council, Via G. Moruzzi 1, 56124 Pisa, Italy. Hauptthemen laut MEDLINE: Ceramides, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is a heterogeneous condition with a prevalence of about 1–3% in the population worldwide (percentage expected to rise), related to a significant clinical and economic burden. However, despite medical advancements in HF management, difficulties in facing this condition still persist, as the etiology and phenotype largely differ between patients. Thus, the identification of further key biomarkers remains attractive. One area of interest in recent years has focused on the role of lipids in HF pathophysiology and its clinical manifestations. In this context, ceramides, complex bioactive lipids with activity in key pathways related to stress response, cellular growth, proliferation, differentiation, apoptosis, oxidative stress, inflammation, and energy production, may be important in the HF scenario, primarily for the development and application of new therapeutic strategies targeting ceramide species. Accordingly, this review aims to discuss the role of ceramides in HF pathophysiology and clinical progression in view of available evidence, focusing on the possibility of therapeutic tools for improving cardiac function and outcomes in HF by modulating ceramide signaling and metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesHeart FailureHumansBiomarkersAnimalsOxidative StressSignal Transduction

Stichwörter der Autor:innen

biomarker discoveryceramidesheart failurelipidomictherapeutic options

Substanzen

CeramidesBiomarkers

Autor:innen und Institutionen

  • Institute of Clinical Physiology, National Research Council, Via G. Moruzzi 1, 56124 Pisa, Italy.
  • Fondazione CNR-Regione Toscana G Monasterio, Via G. Moruzzi 1, 56124 Pisa, Italy.

ORCID-Profile: Melania Gaggini, Cristina Vassalle

Zitieren

APA

Gaggini, M., & Vassalle, C. (2026). Ceramides as Biomarkers and Pharmacological Targets in Heart Failure Pathophysiology. Biomolecules, 16(4), 521. https://doi.org/10.3390/biom16040521

Vancouver

Gaggini M, Vassalle C. Ceramides as Biomarkers and Pharmacological Targets in Heart Failure Pathophysiology. Biomolecules. 2026;16(4):521. doi:10.3390/biom16040521

BibTeX
@article{Gaggini2026,
  author = {Gaggini, Melania and Vassalle, Cristina},
  title = {Ceramides as Biomarkers and Pharmacological Targets in Heart Failure Pathophysiology},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {521},
  doi = {10.3390/biom16040521}
}
Kostenlos starten →